Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial-Reference-Cited by-同舟云学术

Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial

Published:2004-01 Issue:1 Volume:20 Page:121-126
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Hekmat K.¹,Zimmermann T.²,Kampe S.³,Kasper S.M.³,Weber S.M.²,Geissler H.J.¹,Mehlhorn U.¹

Affiliation:

1. Department of Thoracic and Cardiovascular Surgery, University of Cologne, Germany

2. Department of Cardiovascular Engineering, University of Aachen, Juelich, Germany

3. Department of Anesthesiology, University of Cologne, Germany

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079903125002658

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aprotinin in adults at high risk of major blood loss during isolated CABG with cardiopulmonary bypass: a profile of its use in the EU;Drugs & Therapy Perspectives;2019-11-11

2. Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta-analysis;Transfusion;2018-12-05

3. Endocarditis is not an Independent Predictor of Blood Transfusion in Aortic Valve Replacement Patients With Severe Aortic Regurgitation;Journal of Cardiothoracic and Vascular Anesthesia;2016-06

4. Antifibrinolytika–Tranexamsäure und Aprotinin;Transfusionsassoziierte Pharmakotherapie;2015-12-12

5. Aprotinin May Increase Mortality in Low and Intermediate Risk but Not in High Risk Cardiac Surgical Patients Compared to Tranexamic Acid and ε-Aminocaproic Acid – A Meta-Analysis of Randomised and Observational Trials of over 30.000 Patients;PLoS ONE;2013-03-06